Pharmaceutical Business Investment Opportunities

Proposed pharma marketing company focused on general medicine, pain relief, dermatology, and skincare products. - Business plans to operate through a third-party manufacturing model, reducing upfront manufacturing infrastructure costs. - Intends to build and market its own branded pharmaceutical and skincare product portfolio. - Targeting prescription-based and OTC segments with products similar to common general medicine and skincare categories. - Founder is seeking strategic investment to launch operations, build distribution, and scale brand presence in the market. - Business is currently at the pre-operational stage with initial planning and product positioning already identified. - Lean operating structure with low fixed asset requirements due to outsourced manufacturing setup. - Based in Karnal, Haryana, with plans to expand through pharma distributors, medical representatives, and retail pharmacy networks. - The business is currently unregistered and the registration process is underway.

The business operates as a franchised distributor of a generic pharmaceutical manufacturer. - It purchases stock directly from the manufacturer without paying royalties. - The franchise agreement has no fixed tenure and can be renewed easily. - The business serves 25 B2B clients. - It operates as a sole proprietorship with a valid drug license and MSME registration.

Developing a novel pharmaceutical drug targeting the treatment of chronic and episodic migraine conditions. - Designed to address neurological conditions, including trigeminal neuralgia, through specialized therapeutic intervention. - Intended for use in clinical settings under supervision of medical professionals. - Currently in pre-revenue stage with no commercial sales, as the product is awaiting clinical trial progression. - Registered under the FDA IND pathway, indicating initial regulatory alignment for clinical development. - Further regulatory approvals, such as successful completion of clinical trials and drug approval, will be required before commercialization. - Positioned as an early-stage drug development opportunity within the neurology and pain management segment. - Focused on addressing unmet medical needs in migraine and related neurological disorders.

Developing a novel pharmaceutical drug targeting the treatment of chronic and episodic migraine conditions. - Designed to address neurological conditions, including trigeminal neuralgia, through specialized therapeutic intervention. - Intended for use in clinical settings under supervision of medical professionals. - Currently in pre-revenue stage with no commercial sales, as the product is awaiting clinical trial progression. - Registered under the FDA IND pathway, indicating initial regulatory alignment for clinical development. - Further regulatory approvals, such as successful completion of clinical trials and drug approval, will be required before commercialization. - Positioned as an early-stage drug development opportunity within the neurology and pain management segment. - Focused on addressing unmet medical needs in migraine and related neurological disorders.

Pharmaceutical marketing company focused on branded formulations, expanding presence in Delhi and northern India. - Markets a portfolio of products, including Cefixi O tab, Levista AM tab, Vista SP tab, FPM tab, Esom LS Cap, and Vista UP syrup. - Products cater to various therapeutic segments and are prescribed by doctors and healthcare providers. - Operates on an outsourced manufacturing model while selling under its own brand. - Serves 50–60 doctors and clinics, indicating an established prescriber network. - Generates revenue through product sales via medical representatives and direct distribution to clinics. - Led by a promoter with around 20 years of experience in the pharmaceutical industry. - Holds valid drug license, ensuring regulatory compliance. - Built a foundation for expansion with growing doctor network and regional market focus.

• Manufacturer and exporter of homeopathic OTC products, offering a wide portfolio including single remedy pills, dilutions, tablets, pellets, family kits, and blank sugar globules. • Operates as a digitally native, direct-to-consumer (D2C) brand with sales infrastructure built for its own website and major US marketplaces such as Amazon, eBay, and Walmart. • Holds a rare multinational structure with legal entities in the United States, India, and Canada, enabling global operations and regulatory alignment. • Manufacturing facility in India is US FDA registered and has undergone multiple inspections, with only minor observations in the latest review and clearance expected to resume exports. • Owns a US FDA Drug Master File (Type IV) for homeopathic blank pellets, positioning the business as a qualified global supplier of pharmaceutical-grade excipients. • Portfolio includes thousands of OTC SKUs listed with the US FDA, reflecting significant product depth and regulatory groundwork. • Brand is a registered trademark in the United States, strengthening intellectual property protection and market positioning. • Demonstrates strong customer validation through high ratings across major marketplaces and its own platform, indicating product acceptance despite pre-revenue status. • US-based fulfillment center is FDA-inspected with no observations, capable of handling large-scale order volumes and compliant with cGMP standards including recalls and complaint handling. • Backed by a founding team with decades of domain experience in homeopathy and established industry presence. • Built a scalable proprietary e-commerce infrastructure integrated with production systems and third-party platforms, ready to support high SKU and order volumes. • Currently pre-revenue with no sales recorded yet from the India facility; regulatory processes including US FDA inspection are in progress.

Operates a pharmaceutical marketing business focused on selling registered trademark products across India. - Markets products across general medicine, diabetic care, and proton pump inhibitor (PPI) segments. - Supplies to healthcare channels and end customers through an established distribution approach. - Maintains ready stock to support ongoing demand and timely order fulfillment. - Handles approximately 5–6 consignments per week, indicating active operations. - Fully compliant with required regulations, holding valid drug and food licenses.

Pharma marketing business based in Nashik, specializing in generic pharmaceuticals. - Currently, we offer 7 different SKUs of medicines sourced from reliable third-party manufacturers. - We don’t have a single best-seller; our range appeals to various needs. - Our main focus is directly marketing to 24 local doctors and their pharmacies, building solid relationships for consistent referrals. - We have a Wholesale Drug License (WDL), B. GST Registration, and Shop & Establishment Registration. There is no separate license for pharma marketing in Maharashtra. - With a small team of just 2 dedicated employees, we keep operations lean and efficient.

Pharmaceutical manufacturing company producing a wide range of formulations for domestic and international markets. - Operates on a B2B model supplying distributors, pharma companies, and healthcare businesses. - Serves 100+ clients globally and exports products to more than 20 countries. - Handles approximately 30–35 orders per month across different markets. - Manufacturing facility is WHO-GMP certified and designed to meet international quality standards. - Strong presence in ROW (Rest of World) markets with ongoing export operations. - Registered under the Ministry of Corporate Affairs and holds valid GST registration. - Holds required pharmaceutical manufacturing approvals including WHO-GMP certification and USFDA compliance for export-related operations.

Based in Secunderabad, we’re a nutraceutical brand focused on liver support supplements, ready to expand in Hyderabad. - We own our branding and product formulations, but we partner with third party for manufacturing. - Currently, we sell online through our own e-commerce platform and Amazon. - On average, we receive about 50 orders a month, with just one product actively generating revenue so far. - We have a total of 9 SKUs, with 8 more in the pipeline to be launched soon. - Plans are in place to kickstart offline distribution sales to reach more customers. - Our business is fully compliant, holding MCA, GST, and FSSAI registrations. Doesn't have FDA registrations. - Seeking investment to boost our expansion and capitalize on the growing health-conscious market in Hyderabad. - The business is MCA-registered in Hyderabad, while its operational office is located in Secunderabad.

Supplier of pharmaceutical ingredients catering primarily to pharmaceutical manufacturers. - Key products include natural caffeine, synthetic caffeine, Boswellia extract, and Gudmar extract. - Currently operates through an outsourced manufacturing model while focusing on product supply and market distribution. - Serves a large and established customer base of around 1,500 customers in the pharmaceutical manufacturing sector. - Promoter brings over 30 years of experience in the pharmaceutical and ingredient supply industry. - Business operates with required registrations including GST and FSSAI. - Seeking funding to establish an in-house manufacturing facility to increase production control, improve margins, and scale operations.

Skincare manufacturing company, with over 50 years of industry experience. - We primarily serve customers in tier-3 cities, focusing on offline trade to build strong local relationships. - With more than 1 crore users, we have established a vast network of over 1,000 retailers, 100+ distributors, and 4 Super Stockists. - We have been in business relationships with our dealers for 20-25 years, ensuring constant growth and reliability. - Our revenue model is primarily offline, which has helped us create lasting connections and trust with our customers. - We operate under our own brand while also providing manufacturing services for 2-3 other brands on a contract basis. - Our maximum production capacity is INR 30 crores per annum, paving the way for potential expansion into a direct-to-consumer (D2C) brand. - Business has a brand license, GST and a manufacturing license.

Business will operate from a self-owned facility on leased land. - The new plant, Designed to meet USFDA & EU-GMP requirements, is a Greenfield project with a land size of 240,000 sq ft on a 99-year lease. - The built-up area spans 90,000 sq ft and is located in Dewas. - Its scope includes manufacturing oral powder sachets, effervescent tablets, oral liquids, tablets, and capsules, all designed for global compliance. - The promoter have extensive pharmaceutical manufacturing, marketing & distribution experience and an able leadership and marketing team.